Trulicity 3 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F47CG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,936
Award facts
- Contract value 100% obligated
- $18,935.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,935.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of Trulicity 3 mg/0.5 mL pens on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Trulicity is a diabetes management medication commonly used in military treatment facilities and veterans' healthcare programs. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), a major pharmaceutical distributor serving federal agencies including the Department of Veterans Affairs and the Defense Logistics Agency. The company's federal contracting demonstrates consistent capability in fulfilling essential pharmaceutical procurement requirements for government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F47CG?
SPE2DR26F47CG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F47CG worth?
The government has obligated $18,936 on SPE2DR26F47CG.
Is contract SPE2DR26F47CG an order under another contract?
Yes. SPE2DR26F47CG is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47CG competed?
The extent of competition for SPE2DR26F47CG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award